University Hospital Bonn-ko ikertzaileekin lankidetzan egindako argitalpenak (27)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. Genetic Architecture of Ischaemic Strokes after COVID-19 Shows Similarities with Large Vessel Strokes

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

  4. Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery An International Randomized Controlled Trial

    Annals of Internal Medicine, Vol. 176, Núm. 5, pp. 605-614

  5. Thrombectomy versus Medical Management for Isolated Anterior Cerebral Artery Stroke: An International Multicenter Registry Study

    Radiology, Vol. 307, Núm. 2

2022

  1. Center Valve Preference and Outcomes of Transcatheter Aortic Valve Replacement: Insights From the AMTRAC Registry

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 12, pp. 1266-1274

  2. Effect of a Perioperative Hypotension-Avoidance Strategy Versus a Hypertension-Avoidance Strategy on the Risk of Acute Kidney Injury: A Clinical Research Protocol for a Substudy of the POISE-3 Randomized Clinical Trial

    Canadian Journal of Kidney Health and Disease, Vol. 9

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  4. Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery

    Trials, Vol. 23, Núm. 1

  5. Tranexamic Acid in Patients Undergoing Noncardiac Surgery

    New England Journal of Medicine, Vol. 386, Núm. 21, pp. 1996-1997

  6. Transapical mitral valve implantation for treatment of symptomatic mitral valve disease: a real-world multicentre experience

    European Journal of Heart Failure, Vol. 24, Núm. 5, pp. 899-907

2021

  1. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

    Journal of Clinical Investigation, Vol. 131, Núm. 23

  2. Effect of Transcatheter Aortic Valve Replacement on Concomitant Mitral Regurgitation and Its Impact on Mortality

    JACC: Cardiovascular Interventions, Vol. 14, Núm. 11, pp. 1181-1192

  3. Feasibility of Coronary Access in Patients With Acute Coronary Syndrome and Previous TAVR

    JACC: Cardiovascular Interventions, Vol. 14, Núm. 14, pp. 1578-1590

  4. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

    European Journal of Immunology, Vol. 51, Núm. 12, pp. 2708-3145

  5. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. A prospective, international, randomized, noninferiority study comparing an titanium implantable vertebral augmentation device versus balloon kyphoplasty in the reduction of vertebral compression fractures (SAKOS study)

    Spine Journal

  2. Long-Term Outcomes After Infective Endocarditis After Transcatheter Aortic Valve Replacement

    Circulation, Vol. 142, Núm. 15, pp. 1497-1499

  3. Transcatheter Treatment of Residual Significant Mitral Regurgitation Following TAVR: A Multicenter Registry

    JACC: Cardiovascular Interventions, Vol. 13, Núm. 23, pp. 2782-2791

2019

  1. A prospective, international, randomized, noninferiority study comparing an implantable titanium vertebral augmentation device versus balloon kyphoplasty in the reduction of vertebral compression fractures (SAKOS study)

    Spine Journal, Vol. 19, Núm. 11, pp. 1782-1795